Genetic Technologies Return on Investment 2010-2022 | GENE
Current and historical return on investment (ROI) values for Genetic Technologies (GENE) over the last 10 years.
|Genetic Technologies ROI - Return on Investment Historical Data
||TTM Net Income
||LT Investments & Debt
||Return on Investment
||Medical - Biomedical and Genetics
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.